Most of the company’s spending was targeted towards purchase of stock-in-trade, which would increase medicine and medical products PharmEasy sells on its platform. The company spent ₹2,266 ...
Mumbai-based healthtech startup PharmEasy is closing a $100 Mn Series D funding round, a source close to the development told Inc42. The company’s existing investors Eight Roads Ventures India ...
It has now laid off employees across certain verticals like product technology and ... record solutions provider. With this PharmEasy joins the long list of companies that have laid off employees ...
The troubled healthtech startup has received a commitment of INR 2,000 Cr from Temasek Holdings, CDPQ, LGT, Abu Dhabi sovereign wealth fund ADQ, among others Moreover, PharmEasy is likely to get ...